Results
1 -
10 of
50
(Click
here to explore results)
- Allosterism in Drug Discovery, CHAPTER 16 Allosteric Binding in the Serotonin Transporter – Pharmacology, Structure, Function and Potential Use as a Novel Drug Target. Claus J. Loland, Connie Sanchez, Per Plenge, Klaus P. Bøgesø, Benny Bang-Andersen
, 2017
, Pages 360-380
- Drug Discovery for Psychiatric Disorders, CHAPTER 8 Beyond SSRIs: Second-generation Reuptake Inhibitors for the Treatment of Depression. Peter T. Gallagher
, 2012
, Pages 184-225
- Miniaturization and Mass Spectrometry, Chapter 3 A Silicon-based ESI Chip with Integrated Counter Electrode and its Applications Combined with Mass Spectrometry. Gary A. Schultz
, 2009
, Pages 47-66
- Designing Multi-Target Drugs, Chapter 2 Clinical Need and Rationale for Multi-Target Drugs in Psychiatry. Mohammed Shahid
, 2012
, Pages 14-31
- Drug Discovery for Psychiatric Disorders, CHAPTER 19 Multi-target Drug Discovery for Psychiatric Disorders. Zoran Rankovic, Richard Morphy
, 2012
, Pages 510-533
- Accounts in Drug Discovery: Case Studies in Medicinal Chemistry, Chapter 12 A Case History on the Challenges of Central Nervous System and Dual Pharmacology Drug Discovery. Paul V. Fish, Anthony Harrison, Florian Wakenhut, Gavin A. Whitlock
, 2011
, Pages 267-286
- Pain Therapeutics: Current and Future Treatment Paradigms, CHAPTER 5 Neurotransmitters and Other Non-Opiate Central Mechanisms. Simon E. Ward
, 2014
, Pages 171-196
- Designing Multi-Target Drugs, Chapter 10 The Challenges of Multi-Target Lead Optimization. J. Richard Morphy
, 2012
, Pages 141-154
- Pharmaceuticals in the Environment, Distribution of Pharmaceutical Residues in the Environment. Benoit Roig, Vince D’Aco
, 2016
, Pages 34-69
- Capillary Electrophoresis–Mass Spectrometry for Metabolomics, CHAPTER 9 Potential of CE-MS for Chiral Metabolic Profiling. Elena Sánchez-López, María Luisa Marina, Antonio L. Crego
, 2018
, Pages 184-208